Keyphrases
Humoral Immune Response
100%
Cellular Immune Response
100%
Leishmania Donovani
100%
Glucose-regulated Protein 78 (GRP78)
100%
Plasma Samples
42%
Sudanese
42%
Lymphoproliferative Disorders
28%
Antibody Reactivity
28%
Recombinant
28%
Cutaneous Leishmaniasis
28%
Peripheral Blood Mononuclear Cells
28%
L. Major
14%
Leishmanin Skin Test
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Sudan
14%
Vaccine Candidate
14%
Visceral Leishmaniasis
14%
Post-kala-azar Dermal Leishmaniasis
14%
Soluble Leishmania Antigen
14%
T-cell Reactivity
14%
Serosurvey
14%
Ghanaians
14%
Leishmania Vaccine
14%
Danes
14%
Leishmaniasis
14%
Malaria
14%
Malaria Patients
14%
Vaccine Antigen
14%
Immunology and Microbiology
Leishmania donovani
100%
Humoral Immunity
100%
Blood Plasma
100%
Adoptive Immunity
100%
Cutaneous Leishmaniasis
60%
Visceral Leishmaniasis
40%
Peripheral Blood Mononuclear Cell
40%
Leishmaniasis
20%
Leishmania
20%
T Cell
20%
Enzyme-Linked Immunosorbent Assay
20%